COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection

J Nephrol. 2023 Apr;36(3):925-927. doi: 10.1007/s40620-022-01439-1. Epub 2022 Sep 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • nirmatrelvir and ritonavir drug combination